Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study

Annals of Medicine

Volumn 43, Issue SUPPL. 1, 2011, Pages

  Meretoja, Atte ^a   Kaste, Markku ^a   Roine, Risto O ^b   Juntunen, Merja ^c   Linna, Miika ^c   Hillbom, Matti ^d   Marttila, Reijo ^b   Erilä, Terttu ^e   Rissanen, Aimo ^f   Sivenius, Juhani ^g   Häkkinen, Unto ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Benchmarking; follow up studies; mortality; outcome and process assessment (health care); regional differences; registries; specialization; stroke

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DATA BASE; DISEASE REGISTRY; FINLAND; FOLLOW UP; HAZARD RATIO; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STROKE; SUBARACHNOID HEMORRHAGE; SURGEON; SURVIVAL TIME; TREATMENT OUTCOME;

FEMALE; FINLAND; HUMANS; LENGTH OF STAY; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); REGISTRIES; STROKE;

EID: 79958011274     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.586361     Document Type: Article

References (34)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-57. (Pubitemid 43767064)
2. Statistics Finland. HelsinkiAvailable at: http://pxweb2.stat.fi / database/StatFin/databasetree-en.asp. [Last accessed 7 May 2011] .
3. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355-69.
4. World Population Prospects: The 2008 Revision. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. New York, 2008. http:// esa.un.org/unpp. [Last accessed in 7 May 2011] .
5. Sivenius J, Torppa J, Tuomilehto J, Immonen-Raiha P, Kaarisalo M, Sarti C, et al. Modelling the burden of stroke in Finland until 2030. Int J Stroke. 2009;4:340-5.
6. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342:395-8. (Pubitemid 23236352)
7. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283:3102-9. (Pubitemid 30399721)
8. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597-616. (Pubitemid 40973803)
9. Stroke Unit Trialists ' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007:CD000197: published online 2007, doi: 10.1002/ 14651858.CD000197.pub2.
10. Meretoja A, Roine RO, Kaste M, Linna M, Roine S, Juntunen M, et al. Effectiveness of Primary and Comprehensive Stroke Centers. PERFECT Stroke: A Nationwide Observational Study from Finland. Stroke. 2010;41: 1102-7.
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-7.
12. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-703.
13. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13. (Pubitemid 26402780)
14. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-73.
15. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329-39.
16. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35:1024-1033.
17. Amarenco P, Bogousslavsky J, Callahan A, 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-59. (Pubitemid 44202151)
18. European Stroke Initiative recommendations for stroke management. European Stroke Council, European Neurological Society and European Federation of Neurological Societies. Cerebrovasc Dis. 2000;10:335-51.
19. ESO. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Cerebrovasc Dis. 2008;25:457-507.
20. Kaste M, Sairanen T, Häpp ö läO, Lassila R, Lepäntalo M, Lindsberg PJ, et al. Aivoinfarkti. Käypähoito -suositus. [In Finnish Cerebral Infarction. Current care guidelines.]. Duodecim. 2006;122:2770-90.
21. Kjellstrom T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis. 2007;23:231-41.
22. Peltola M, Juntunen M, Häkkinen U, Rosenqvist G, SeppäläT, Sund R. A methodological approach for register-based evaluation of cost and outcomes in health care. Ann Med. 2011;43:S4-13.
23. Gissler M, Haukka J. Finnish health and social welfare registers in epidemiological research. Norwegian J Epidemiol. 2004;14:113-20.
24. Meretoja A, Kaste M, Roine RO, Juntunen M, Linna M, Hillbom M, et al. Direct Costs of Stroke Patients can be Continuously Monitored on a National Level. PERFECT Stroke Database in Finland. Stroke. 2011;42: published online 28 April 2011, doi: 10.1161/STROKEAHA. 110.612119 .
25. Meretoja A, Roine RO, Kaste M, Linna M, Juntunen M, Erila T, et al. Stroke monitoring on a national level. PERFECT Stroke, a comprehensive, registry-linkage stroke database in Finland. Stroke. 2010;41:2239-46.
26. Kaste M, Palomaki H, Sarna S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke. 1995;26:249-53.
27. Smith MA, Liou JI, Frytak JR, Finch MD. 30-day survival and rehospitalization for stroke patients according to physician specialty. Cerebrovasc Dis. 2006;22:21-6. (Pubitemid 43875156)
28. Simonen O, Kaste M, Sivenius J, Sotaniemi K, Räsänen R, Hiltunen R, et al. Aivoverenkiertohäiri ö t. Vaaratekijät, ehkäisyn, tutkimuksen, hoidon ja kuntoutuksen järjestäminen [in Finnish; National Board of Health Statements; Cerebrov-ascular disorders: risk factors, prevention, diagnosis, treatment and rehabilitation]. 1989. Lää kint ö hallituksen ty ö ryhmien mietint ö jä1989:3. Valtion painatuskeskus. Helsinki.
29. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-7.
30. National Development Plan for Social and Health Care Services. Kaste Programme 2008-2011. Publications of the Ministry of Social Affairs and Health, Finland. 2008:6.
31. Numminen H, Kaste M, Aho K, Waltimo O, Kotila M. Decreased severity of brain infarct can in part explain the decreasing case fatality rate of stroke. Stroke. 2000;31: 651-5. (Pubitemid 30131650)
32. Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke. 2010;41: 1450-8.
33. Sivenius J, Tuomilehto J, Immonen-RäihäP, Kaarisalo M, Sarti C, Torppa J, et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke. 2004;35:420-5. (Pubitemid 38174423)
34. Asplund K, Hulter Asberg K, Appelros P, Bjarne D, Eriksson M, Johansson A, et al. The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care. Int J Stroke. 2011;6:99-108.